Trial
NCT01360671
IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Persistent Pulmonary Hypertension of the Newborn
Intervention
Sildenafil
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-02